Back
BetaPro S&P/TSX Cap Engy -2xDlyBear ETF Vs. Neurogene Industry Stock Comparison
Buy
54
HED.TO
BetaPro S&P/TSX Cap Engy -2xDlyBear ETF
Last Price:
3.87
Seasonality Move:
-1.44%
Sell
5
NGNE
Neurogene
Last Price:
39.96
Seasonality Move:
50.43%
Buy
54
BetaPro S&P/TSX Cap Engy -2xDlyBear ETF (HED.TO)
is a Buy
Is BetaPro S&P/TSX Cap Engy -2xDlyBear ETF a Buy, Sell or Hold?
- The current BetaPro S&P/TSX Cap Engy -2xDlyBear ETF [HED.TO] share price is $4.03. The Score for HED.TO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- HED.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
5
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
HED.TO Stock Price Chart
What is BetaPro S&P/TSX Cap Engy -2xDlyBear ETF's stock price today?
-
The BetaPro S&P/TSX Cap Engy -2xDlyBear ETF share price today is $4.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HED.TO is experiencing selling pressure, which indicates risk of future bearish movement.
HED.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 48.96 | Sell |
Chaikin Money Flow: | -7027 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.86 - 4.12) | Buy |
Bollinger Bands (100): | (3.81 - 4.35) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.3 | Buy |
Relative Strength Index (14 RSI): | 39.1 | Sell |
Chaikin Money Flow: | -346626 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.29 - 61.53) | Sell |
Bollinger Bands (100): | (34.11 - 50.51) | Sell |
HED.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.04 | Sell |
20-day SMA: | 4.03 | Buy |
50-day SMA: | 4.19 | Sell |
200-day SMA: | 4.2 | Sell |
8-day EMA: | 4.04 | Sell |
20-day EMA: | 4.04 | Sell |
50-day EMA: | 4.08 | Sell |
200-day EMA: | 4.34 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.39 | Sell |
20-day SMA: | 53.17 | Sell |
50-day SMA: | 46.66 | Sell |
200-day SMA: | 38.93 | Buy |
8-day EMA: | 54.03 | Sell |
20-day EMA: | 53.18 | Sell |
50-day EMA: | 48.36 | Sell |
200-day EMA: | 38.47 | Buy |
BetaPro S&P/TSX Cap Engy -2xDlyBear ETF Earnings Growth & HED.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
BetaPro S&P/TSX Cap Engy -2xDlyBear ETF Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |